Form 4: Accuray COO Granted 125,000 Restricted Stock Units

Accuray's SVP and Chief Operations Officer, Leonel Peralta, was granted 125,000 Restricted Stock Units, vesting over three years.

Summary

• Leonel Peralta, SVP, Chief Operations Officer of Accuray Inc. (ARAY), was granted 125,000 Restricted Stock Units (RSUs).
• The transaction date for this grant was November 28, 2025.
• Each RSU represents a contingent right to receive one share of Accuray's common stock.
• The RSUs will vest and be released in three tranches: 34% on the first anniversary of the vesting commencement date, 33% on the second anniversary, and 33% on the third anniversary.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as the RSU grant aligns executive interests with shareholders and supports retention, which is generally viewed favorably. However, it is a routine compensation event and not indicative of significant operational or financial news.

Positives

• The grant of 125,000 Restricted Stock Units to a key executive like the SVP, Chief Operations Officer, aligns management's interests with those of shareholders.
• This form of equity compensation serves as a retention mechanism for senior leadership.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction, focusing solely on an executive compensation grant.

Industry Context

The grant of Restricted Stock Units (RSUs) to senior executives is a common practice in the technology and medical device industries, including companies like Accuray, to incentivize performance, align executive interests with shareholders, and ensure long-term retention.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a form of executive compensation is a standard practice across various industries, including medical technology, aligning with compensation strategies seen at companies such as Intuitive Surgical (ISRG) or Stryker Corporation (SYK).
• The multi-year vesting schedule (34%, 33%, 33% over three years) is typical for RSU grants, designed to encourage long-term commitment and performance, comparable to vesting schedules observed in similar-sized public companies.

Stakeholder Impact

• Shareholders: The RSU grant aligns the interests of the SVP, Chief Operations Officer, with those of shareholders, potentially incentivizing long-term value creation.
• Employees: This compensation structure for a senior executive may signal stability in leadership and a commitment to retaining key talent.

Next Steps

• The vesting of the granted Restricted Stock Units will occur on the first, second, and third anniversaries of the November 28, 2025 commencement date.

Key Dates

Keywords

ACCURAY, ARAY, Form 4, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Equity Grant